Raleigh-based Helixomer, a pre-clinical, drug-development company created at North Carolina State University, has won a $2 million federal grant to advance a pair of novel drugs to regulate bleeding and clotting in patients.
Raleigh-based Helixomer, a pre-clinical, drug-development company created at North Carolina State University, has won a $2 million federal grant to advance a pair of novel drugs to regulate bleeding and clotting in patients.
Venture Day 2022 Highlights Early-stage Life-science Companies in the Triangle – Duke OTC duke.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from duke.edu Daily Mail and Mail on Sunday newspapers.